Welcome to the CIRB

The Central Institutional Review Board for the National Cancer Institute

Our priority is to protect the participants in adult and pediatric clinical trials.
We serve institutions across the nation in conducting NCI sponsored research.
Our national team of experts ensures that the studies are reviewed to meet the highest ethical and quality standards.

NCI CIRB INFORMATION ABOUT COVID-19 

(Updated March 30, 2020)

 

A new NCI CIRB Information About COVID-19 page contains information to help the research community when addressing the outbreak of COVID-19 within the context of CIRB approved clinical trials.  The NCI CIRB is working closely with NCI and will keep this page updated as new information arises.